United States · FDA National Drug Code directory

Paroxetine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62175-472_9474f942-d6d8-486b-8ea6-f8c561bb5014
Product NDC: 62175-472
Form: TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term: Paroxetine Hydrochloride
Labeler: Lannett Company, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20141031
Source listing expiry: 20261231

Source-listed ingredients

PAROXETINE HYDROCHLORIDE — 37.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62175-472-32) · 62175-472-32
500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62175-472-41) · 62175-472-41

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →